India's CRDMO Market to Reach $25 Billion by 2035: BCG-IPSO Report

India's CRDMO sector has good potential for growth, with the estimated size of the market projected to...

Union Health Secretary Urges Stronger Drug Regulations for Quality Control

In a meeting of state drug regulators held on Monday under the Nasha Mukt Bharat Abhiyan, Union Health Secretary Punya Salila Srivastav stressed the...

India poised to become a Global Hub for Clinical Trials: Exec

India is prepared to take over as a substitute location for early-stage clinical studies in order to lessen the effects of interruptions like the conflict between Russia and Ukraine, an executive at contract research firm Parexel said.

Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth

BioAsia 2025 has set the stage for Hyderabad to solidify its position as a global life sciences hub. With 11 pharmaceutical companies pledging investments worth Rs 5,445 crore and creating 9,800 jobs, the sector is witnessing strong momentum. The tot

Mankind Pharma Unveils World's First Oral Small-Molecule Anti-Obesity Drug

Mankind Pharma, known for its Manforce condoms and Prega News pregnancy tests, has presented a formulation for...

Dr. Reddy's Confirms Indian Drugmakers to Stay Competitive Despite Tariffs

The Indian pharmaceutical industry remains robust in spite of potential trade challenges as U.S. President Donald Trump considers imposing tariffs on medication imports. Industry specialists are assured that Indian pharmaceutical firms will retain th

Marksans' Relonchem Wins Approval for Ibuprofen, Paracetamol Tablets

According to Marksans Pharma, its subsidiary company, Relonchem, has received marketing authorization for...

Indian Pharma Sees 8.4% Growth in Jan 2025, Boosted by Chronic Care

The Indian pharmaceutical market climbed to a year-on-year growth of 8.4% in January 2025, finding its feet with the assistance of...

Indian Pharma Plans Global Expansion as U.S. Tariff Looms

The pharmaceutical enterprises in India to expand their market beyond the United States, as Trump administration proposed a tariff of...

Amgen to Invest $200M in AI-Driven Innovation Hub in India

US biopharma Amgen is allocating USD 200 million this year for its new facility in the region and intends to make substantial investments in the upcoming years, stated CEO Robert Bradway on Monday.

© 2025 India Pharma Outlook. All Rights Reserved.